The Icelandic mutation in the amyloid precursor protein (APP), APP<sup>A673T</sup>, has been identified in Icelandic and Scandinavian populations and is associated with a significantly lower risk of developing Alzheimer's disease (AD). Here, APP is linked to Alzheimer disease.